tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Invivyd says PEMGARDA  effective against XFG variant of SARS-CoV-2
PremiumThe FlyInvivyd says PEMGARDA effective against XFG variant of SARS-CoV-2
4d ago
Invivyd’s Transformative Year: Regulatory Advances and Market Potential Drive Buy Rating
Premium
Ratings
Invivyd’s Transformative Year: Regulatory Advances and Market Potential Drive Buy Rating
4d ago
Invivyd Aligns with FDA for Rapid Approval Pathway
Premium
Company Announcements
Invivyd Aligns with FDA for Rapid Approval Pathway
8d ago
Invivyd forms SPEAR study group to assess therapy for long-COVID
PremiumThe FlyInvivyd forms SPEAR study group to assess therapy for long-COVID
2M ago
Invivyd’s VYD2311: Promising Phase 1/2 Trial Results and Strategic Positioning Support Buy Rating
Premium
Ratings
Invivyd’s VYD2311: Promising Phase 1/2 Trial Results and Strategic Positioning Support Buy Rating
2M ago
Invivyd Announces Positive Phase 1/2 Trial Results
Premium
Company Announcements
Invivyd Announces Positive Phase 1/2 Trial Results
2M ago
Invivyd announces PEMGARDA has been added to NCCN Clinical Practice Guidelines
PremiumThe FlyInvivyd announces PEMGARDA has been added to NCCN Clinical Practice Guidelines
3M ago
Invivyd ‘commends’ FDA focus on uncertainty around COVID-19 vaccine boosters
Premium
The Fly
Invivyd ‘commends’ FDA focus on uncertainty around COVID-19 vaccine boosters
3M ago
Invivyd Holds Annual Stockholders Meeting, Elects Directors
Premium
Company Announcements
Invivyd Holds Annual Stockholders Meeting, Elects Directors
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100